Human IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT640-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Cirino Botta Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients J Immunother 2012 35 440-7
Alexander Strom Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6 Cytokine 2012 58 148-51
Lynda Bererhi Clinical and immunological features of very long-term survivors with a single renal transplant Transpl Int 2012 25 545-54
P Correale Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro Int J Cancer 2012 130 1577-89
Xiangmei Wu Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays Autoimmunity 2012 45 176-85
Karsten Buschard Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells PLoS One 2012 7 e52639
Wendy Unger Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice PLoS One 2012 7 e49213
Aaron Michels Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation J Immunol 2011 187 5921-30
E James Immunology of Diabetes Society T-Cell Workshop: HLA class II tetramer-directed epitope validation initiative Diabetes Metab Res Rev 2011 27 727-36
R Mallone Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative Diabetes Metab Res Rev 2011 27 720-6